These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 35730965)

  • 1. Comparative Genomics of Shiga Toxin-Producing Escherichia coli Strains Isolated from Pediatric Patients with and without Hemolytic Uremic Syndrome from 2000 to 2016 in Finland.
    Bai X; Ylinen E; Zhang J; Salmenlinna S; Halkilahti J; Saxen H; Narayanan A; Jahnukainen T; Matussek A
    Microbiol Spectr; 2022 Aug; 10(4):e0066022. PubMed ID: 35730965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide association study of hemolytic uremic syndrome causing Shiga toxin-producing Escherichia coli from Sweden, 1994-2018.
    Matussek A; Mernelius S; Chromek M; Zhang J; Frykman A; Hansson S; Georgieva V; Xiong Y; Bai X
    Eur J Clin Microbiol Infect Dis; 2023 Jun; 42(6):771-779. PubMed ID: 37103716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative genomic analysis of a Shiga toxin-producing Escherichia coli (STEC) O145:H25 associated with a severe pediatric case of hemolytic uremic syndrome in Davidson County, Tennessee, US.
    Guerra JA; Zhang C; Bard JE; Yergeau D; Halasa N; Gómez-Duarte OG
    BMC Genomics; 2020 Aug; 21(1):564. PubMed ID: 32807093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Characterization of Intimin Gene (
    Wang L; Bai X; Ylinen E; Zhang J; Saxén H; Matussek A
    Toxins (Basel); 2023 Nov; 15(12):. PubMed ID: 38133173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-genome characterization of hemolytic uremic syndrome-causing Shiga toxin-producing
    Hua Y; Chromek M; Frykman A; Jernberg C; Georgieva V; Hansson S; Zhang J; Marits AK; Wan C; Matussek A; Bai X
    Virulence; 2021 Dec; 12(1):1296-1305. PubMed ID: 33939581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative genomics to delineate pathogenic potential in non-O157 Shiga toxin-producing Escherichia coli (STEC) from patients with and without haemolytic uremic syndrome (HUS) in Norway.
    Haugum K; Johansen J; Gabrielsen C; Brandal LT; Bergh K; Ussery DW; Drabløs F; Afset JE
    PLoS One; 2014; 9(10):e111788. PubMed ID: 25360710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemolytic uremic syndrome due to Shiga toxin-producing Escherichia coli infection.
    Bruyand M; Mariani-Kurkdjian P; Gouali M; de Valk H; King LA; Le Hello S; Bonacorsi S; Loirat C
    Med Mal Infect; 2018 May; 48(3):167-174. PubMed ID: 29054297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli in children: incidence, risk factors, and clinical outcome.
    Ylinen E; Salmenlinna S; Halkilahti J; Jahnukainen T; Korhonen L; Virkkala T; Rimhanen-Finne R; Nuutinen M; Kataja J; Arikoski P; Linkosalo L; Bai X; Matussek A; Jalanko H; Saxén H
    Pediatr Nephrol; 2020 Sep; 35(9):1749-1759. PubMed ID: 32323005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shiga Toxin-Producing
    Bai X; Mernelius S; Jernberg C; Einemo IM; Monecke S; Ehricht R; Löfgren S; Matussek A
    Front Cell Infect Microbiol; 2018; 8():125. PubMed ID: 29765909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bloody Diarrhea and Shiga Toxin-Producing Escherichia coli Hemolytic Uremic Syndrome in Children: Data from the ItalKid-HUS Network.
    Ardissino G; Vignati C; Masia C; Capone V; Colombo R; Tel F; Daprai L; Testa S; Dodaro A; Paglialonga F; Luini M; Brigotti M; Picicco D; Baldioli C; Pagani F; Ceruti R; Tommasi P; Possenti I; Cresseri D; Consonni D; Montini G; Arghittu M;
    J Pediatr; 2021 Oct; 237():34-40.e1. PubMed ID: 34197890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characteristics of
    Hua Y; Bai X; Zhang J; Jernberg C; Chromek M; Hansson S; Frykman A; Yang X; Xiong Y; Wan C; Matussek A
    Emerg Microbes Infect; 2020 Dec; 9(1):2562-2570. PubMed ID: 33179570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shiga toxin-producing escherichia coli infections in Norway, 1992-2012: characterization of isolates and identification of risk factors for haemolytic uremic syndrome.
    Brandal LT; Wester AL; Lange H; Løbersli I; Lindstedt BA; Vold L; Kapperud G
    BMC Infect Dis; 2015 Aug; 15():324. PubMed ID: 26259588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Characterization of Shiga Toxin-Producing Escherichia coli Strains Isolated in Poland.
    Januszkiewicz A; Rastawicki W
    Pol J Microbiol; 2016 Aug; 65(3):261-269. PubMed ID: 29334059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Characterization of the Enterohemolysin Gene (
    Hua Y; Zhang J; Jernberg C; Chromek M; Hansson S; Frykman A; Xiong Y; Wan C; Matussek A; Bai X
    Toxins (Basel); 2021 Jan; 13(1):. PubMed ID: 33477906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemolytic uremic syndrome associated with Shiga toxin-producing Escherichia coli infection in Argentina: update of serotypes and genotypes and their relationship with severity of the disease.
    Alconcher LF; Balestracci A; Coccia PA; Suarez ADC; Ramírez FB; Monteverde ML; Perez Y Gutiérrez MG; Carlopio PM; Principi I; Estrella P; Micelli S; Leroy DC; Quijada NE; Seminara C; Giordano MI; Hidalgo Solís SB; Saurit M; Caminitti A; Arias A; Liern M; Rivas M
    Pediatr Nephrol; 2021 Sep; 36(9):2811-2817. PubMed ID: 33604727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between Shiga Toxin-Producing Escherichia coli O157:H7 stx Gene Subtype and Disease Severity, England, 2009-2019.
    Byrne L; Adams N; Jenkins C
    Emerg Infect Dis; 2020 Oct; 26(10):2394-2400. PubMed ID: 32946720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virulence factors of Shiga toxin-producing Escherichia coli and the risk of developing haemolytic uraemic syndrome in Norway, 1992-2013.
    Naseer U; Løbersli I; Hindrum M; Bruvik T; Brandal LT
    Eur J Clin Microbiol Infect Dis; 2017 Sep; 36(9):1613-1620. PubMed ID: 28391537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterisation of human Shiga toxin-producing
    Usein CR; Ciontea AS; Militaru CM; Condei M; Dinu S; Oprea M; Cristea D; Michelacci V; Scavia G; Zota LC; Zaharia A; Morabito S
    Euro Surveill; 2017 Nov; 22(47):. PubMed ID: 29183554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infections in pediatric postdiarrheal hemolytic uremic syndrome: factors associated with identifying shiga toxin-producing Escherichia coli.
    Mody RK; Luna-Gierke RE; Jones TF; Comstock N; Hurd S; Scheftel J; Lathrop S; Smith G; Palmer A; Strockbine N; Talkington D; Mahon BE; Hoekstra RM; Griffin PM
    Arch Pediatr Adolesc Med; 2012 Oct; 166(10):902-9. PubMed ID: 22869280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody response to lipopolysaccharides and recombinant proteins of Shiga toxin (STX)-producing Escherichia coli (STEC) in children with haemolytic uraemic syndrome in Poland.
    Rastawicki W; Śmietańska K; Rokosz-Chudziak N; Wołkowicz T
    Lett Appl Microbiol; 2020 Jun; 70(6):440-446. PubMed ID: 32270510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.